Skip to section navigation
Skip to page content

Innovation in Health and Care

Helping policy and other decisionmakers understand how to use innovation to manage global healthcare burdens and improve innovation initiatives in the healthcare system

Featured initiative

Navigating and improving healthcare innovation, industry and policy
RAND Europe helps decisionmakers navigate the changing societal, scientific and technological landscape to identify solutions that positively impact the health of populations and healthcare systems globally.

Research, commentary, and events

Commentary
Microbiome-Based Health and Wellness Innovation
Microbiome research and development may lead to an increasing number of therapeutic and well-being breakthroughs. But regulating microbiota-related products poses a challenge that could require innovative approaches.
06 Jul 2022
Commentary
Diversity, Equality, and Inclusion in Health Care Innovation
For health care innovations to have the fairest and broadest possible benefit to society, efforts could be made to attend to all stages of the innovation pathway to identify opportunities to mitigate biases through diversity, equality, and inclusion.
06 Jul 2022
Project
Understanding the financial ecosystem surrounding the development of medicines
To enable governments to make more informed policy decisions that optimise value for their citizens, while at the same time appropriately reimbursing innovators, researchers explored the evidence base on how medicines R&D is financed and how this may evolve in the future.
23 Jun 2022
Commentary
When IT Meets Medical Innovation: Regulatory and Policy Challenges for Software as a Medical Device
The demand for using software to improve health care, including software as a medical device (SaMD), is on the rise. Realizing the potential benefits of the growing demand for SaMD may require clearer and more-consistent regulation of patient safety and medical effectiveness.
10 Jun 2022
Project
The impact of respiratory syncytial virus on the NHS, society and economy in the UK
Researchers estimate the total economic impact of respiratory syncytial virus (RSV) to be around £80 million each year, based on a rapid evidence assessment to model the disease's wider societal and economic burden in the UK.
31 May 2022
Project
New insights into the medical use of cannabis
Researchers are examining the latest developments and available evidence concerning the medical use of cannabis and cannabinoids for the European Monitoring Centre for Drugs and Drug Addiction.
17 May 2022
Project
The impact of predictive genetic tests on the insurance industry
Researchers developed a framework for evaluating the potential effects of predictive genetic tests on the UK insurance industry. The framework provides a transparent approach for evaluating whether a specific condition for which a test is available could impact the insurance industry and understanding the key factors that influence this.
08 Apr 2022
Project
Diagnosis, treatment and management of central diabetes insipidus
RAND Europe was commissioned by Ferring Pharmaceuticals to look at care pathways for patients with CDI. The research focused on identifying the factors that influence the diagnosis, treatment and management of patients with CDI, as well as areas to consider that may improve the quality of care that patients receive, and patient outcomes.
07 Mar 2022
Project
Evaluating the progress and impacts of the COG-UK consortium
An evaluation of the COVID-19 Genomics UK (COG-UK) consortium finds that it has made a significant and valuable contribution to the UK's public health genomics landscape, but its legacy will depend on decision makers' abilities to maintain momentum, ensure adequate governance, and other factors.
15 Feb 2022
Project
Understanding industry contributions to the fight against antimicrobial resistance
The AMR Industry Alliance brings together over 100 biotechnology, diagnostic, generics and research-based biopharmaceutical companies and trade associations in the fight against AMR. RAND Europe assessed the progress of AMRIA members in contributing to tackling AMR and found they are making a difference on diverse fronts.
01 Feb 2022
Project
Assessing EHR for infectious disease surveillance, prevention and control
Electronic health records (EHR) data could greatly help infectious disease surveillance, but their use varies across Europe. Researchers mapped EHR use to assess the feasibility of using EHR data for infectious disease surveillance.
10 Dec 2021
Report
The potential socio-economic impact of telemedicine in Canada
RAND Europe researchers examined the potential impact in Canada of continued, long-term use of telemedicine, which can include the use of 'smart' devices to conduct medical tests, the digital storage and sharing of medical records, and real-time tele-consultations between healthcare providers and patients.
06 Dec 2021
Research Brief
Greater telemedicine adoption in Canada could offer economic and social benefits
Alongside the benefits from tools such as telemonitoring and digital health records, researchers found that widespread use of teleconsultations could lead to significant benefits for Canadian patients, the Canadian economy and wider Canadian society.
06 Dec 2021
Commentary
What Are the Practical Considerations for Outcome-Based Payment in the NHS?
Uncertainty can surround the effectiveness or cost-effectiveness of a new medicine, making it difficult to agree on a medicine's price. One solution to avoid unduly delaying or restricting patients' access is to link the medicine's price to the outcomes it produces in a patient. Despite some barriers, outcome-based payment could offer a “win” for patients, the NHS, and industry.
02 Dec 2021
Project
Assessing POCT for infectious disease surveillance, prevention and control
Researchers examined the availability of point-of-care testing (POCT) devices to diagnose 56 communicable diseases and related health issues under EU surveillance — not including COVID-19 — and mapped trends in the use of POCT in Europe.
02 Dec 2021

Page 1 of 4
1
2
3
4
Next